Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
RATIONALE: Phosphodiesterase Type 5 (PDE5) inhibition represents a novel strategy for the treatment of pulmonary hypertension. OBJECTIVES: Our aim was to establish the distribution of PDE5 in the pulmonary vasculature and effects of PDE5 inhibition on pulmonary artery smooth muscle cells (PASMCs). METHODS AND MEASUREMENTS: PDE5 expression was examined by immunohistochemistry and Western blotting, in both normal and hypertensive lung tissues. DNA synthesis, proliferation, PDE activity, and apoptosis were measured in distal human PASMCs treated with soluble guanylyl cyclase activators (nitric oxide donors and BAY41-2272) and sildenafil. MAIN RESULTS: Cells containing PDE5 and alpha-smooth muscle actin occurred throughout the pulmonary vasculature, including obstructive intimal lesions. Three molecular forms of PDE5 were identified and protein expression was greater in hypertensive than control lung tissue. Most cyclic guanosine monophosphate hydrolysis (about 80%) in cultured cells was attributed to PDE5. Sildenafil induced a greater elevation of intracellular cyclic guanosine monophosphate levels compared with nitric oxide donors and BAY41-2272 (about 10-fold versus about 2-fold) and cotreatment had a synergistic effect, increasing cyclic nucleotide levels up to 50-fold. Dual stimulation of soluble guanylyl cyclase and inhibition of PDE5 activities also had significant downstream effects, increasing phosphorylation of vasodilator-stimulated phosphoprotein, reducing DNA synthesis and cell proliferation, and stimulating apoptosis, and these effects were mimicked by cyclic guanosine monophosphate analogs. CONCLUSIONS: Phosphodiesterase Type 5 is the main factor regulating cyclic guanosine monophosphate hydrolysis and downstream signaling in human PASMCs. The antiproliferative effects of this signaling pathway may be significant in the chronic treatment of pulmonary hypertension with PDE5 inhibitors such as sildenafil.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perkins, D. N., Pappin, D. J. C., Creasy, D. M., & Cottrell, J. S. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19991201)20:18<3551::aid-elps3551>3.0.co;2-2 · Cited by 8,203
Garg, U. C., & Hassid, A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114081 · Cited by 2,155
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Cattoretti, G., Pileri, S., Parravicini, C., Becker, M. H. G., Poggi, S., Bifulco, C., Key, G., D'Amato, L., Sabattini, E., Feudale, E., et al. (1993) · The Journal of Pathology · doi:10.1002/path.1711710205 · Cited by 721
Michelakis, E., Tymchak, W., Lien, D., Webster, L., Hashimoto, K., & Archer, S. (2002) · Circulation · doi:10.1161/01.cir.0000016641.12984.dc · Cited by 577
Primary pulmonary hypertension
Runo, J. R., & Loyd, J. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13167-4 · Cited by 521
Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function
Rybalkin, S. D., Yan, C., Bornfeldt, K. E., & Beavo, J. A. (2003) · Circulation Research · doi:10.1161/01.res.0000087541.15600.2b · Cited by 511
Wallis, R. M., Corbin, J. D., Francis, S. H., & Ellis, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00042-9 · Cited by 504
Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension
Zhao, L., Mason, N. A., Morrell, N. W., Kojonazarov, B., Sadykov, A., Maripov, A., Mirrakhimov, M. M., Aldashev, A., & Wilkins, M. R. (2001) · Circulation · doi:10.1161/hc2901.093117 · Cited by 488
Self-citationPharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man
WALKER, D. K. (1999) · Xenobiotica · doi:10.1080/004982599238687 · Cited by 401
Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension
Wilkens, H., Guth, A., König, J., Forestier, N., Cremers, B., Hennen, B., Böhm, M., & Sybrecht, G. W. (2001) · Circulation · doi:10.1161/hc3601.096826 · Cited by 392
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study
Wilkins, M. R., Paul, G. A., Strange, J. W., Tunariu, N., Gin-Sing, W., Banya, W. A., Westwood, M. A., Stefanidis, A., Ng, L. L., Pennell, D. J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1411oc · Cited by 380
Self-citationPollman, M. J., Yamada, T., Horiuchi, M., & Gibbons, G. H. (1996) · Circulation Research · doi:10.1161/01.res.79.4.748 · Cited by 341
ET A and ET B Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells
DAVIE, N., HALEEN, S. J., UPTON, P. D., POLAK, J. M., YACOUB, M. H., MORRELL, N. W., & WHARTON, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.3.2104059 · Cited by 314
Self-citationGhofrani, H. A., Reichenberger, F., Kohstall, M. G., Mrosek, E. H., Seeger, T., Olschewski, H., Seeger, W., & Grimminger, F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-3-200408030-00005 · Cited by 309
Overall cardiovascular profile of sildenafil citrate
Zusman, R. M., Morales, A., Glasser, D. B., & Osterloh, I. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00046-6 · Cited by 307
Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H. A., SCHERMULY, R. T., Rose, F., Wiedemann, R., Kohstall, M. G., Kreckel, A., Olschewski, H., Weißmann, N., Enke, B., Ghofrani, S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1157bc · Cited by 283
Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension
Sebkhi, A., Strange, J. W., Phillips, S. C., Wharton, J., & Wilkins, M. R. (2003) · Circulation · doi:10.1161/01.cir.0000074226.20466.b1 · Cited by 261
Self-citationChronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats
SCHERMULY, R. T., Kreisselmeier, K. P., Ghofrani, H. A., Yilmaz, H., BUTROUS, G. S., Ermert, L., Ermert, M., Weißmann, N., Rose, F., Guenther, A., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-282oc · Cited by 256
Oelze, M., Mollnau, H., Hoffmann, N., Warnholtz, A., Bodenschatz, M., Smolenski, A., Walter, U., Skatchkov, M., Meinertz, T., & Münzel, T. (2000) · Circulation Research · doi:10.1161/01.res.87.11.999 · Cited by 253
Sildenafil Inhibits Altitude-induced Hypoxemia and Pulmonary Hypertension
Richalet, J.-P., Gratadour, P., Robach, P., Pham, I., Déchaux, M., Joncquiert-Latarjet, A., Mollard, P., Brugniaux, J., & Cornolo, J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-804oc · Cited by 245
Regulation of cGMP-specific Phosphodiesterase (PDE5) Phosphorylation in Smooth Muscle Cells
Rybalkin, S. D., Rybalkina, I. G., Feil, R., Hofmann, F., & Beavo, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106562200 · Cited by 218
Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors
Rabe, K. F., Tenor, H., Dent, G., Schudt, C., Nakashima, M., & Magnussen, H. (1994) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1994.266.5.l536 · Cited by 183
Chiche, J.-D., Schlutsmeyer, S. M., Bloch, D. B., de la Monte, S. M., Roberts, J. D., Filippov, G., Janssens, S. P., Rosenzweig, A., & Bloch, K. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34263 · Cited by 161
Wharton, J., Davie, N. J., Upton, P. D., Yacoub, M. H., Polak, J. M., & Morrell, N. W. (2000) · Circulation · doi:10.1161/01.cir.102.25.3130 · Cited by 161
Self-citationLin, C.-S., Lau, A., Tu, R., & Lue, T. F. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2187 · Cited by 159
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
Rybalkin, S. D., Rybalkina, I. G., Beavo, J. A., & Bornfeldt, K. (2002) · Circulation Research · doi:10.1161/hh0202.104108 · Cited by 123
A Combination of Oral Sildenafil and Beraprost Ameliorates Pulmonary Hypertension in Rats
Itoh, T., Nagaya, N., Fujii, T., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-346oc · Cited by 104
Tissue expression, distribution, and regulation of PDE5
Lin, C.-S. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901207 · Cited by 98
Zhao, L., Mason, N. A., Strange, J., Walker, H., & Wilkins, M. R. (2003) · Circulation · doi:10.1161/01.cir.0000050653.10758.6b · Cited by 98
Self-citationChen, L., Daum, G., Chitaley, K., Coats, S. A., Bowen‐Pope, D. F., Eigenthaler, M., Thumati, N. R., Walter, U., & Clowes, A. W. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000134705.39654.53 · Cited by 93
Shepherd, M. C., Baillie, G. S., Stirling, D., & Houslay, M. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705770 · Cited by 91
Cl- current activation in choroid plexus epithelial cells involves a G protein and protein kinase A
Kotera, T., & Brown, P. D. N. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.2.c536 · Cited by 88
Ca/CaM-Stimulated and cGMP-Specific Phosphodiesterases in Vascular and Non-Vascular Tissues
Ahn, H. S., Foster, M., Cable, M., Pitts, B. J. R., & Sybertz, E. J. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-6015-5_15 · Cited by 81
The Role of the NO Axis and its Therapeutic Implications in Pulmonary Arterial Hypertension
Michelakis, E. D. (2003) · Heart Failure Reviews · doi:10.1023/a:1022150819223 · Cited by 69
The Role of the NO Axis and its Therapeutic Implications in Pulmonary Arterial Hypertension
Michelakis, E. D. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7960-5_19 · Cited by 67
Osinski, M., Rauch, B. H., & Schrör, K. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1044 · Cited by 67
Lin, C., Chow, S., Lau, A., Tu, R., & Lue, T. F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4221 · Cited by 54
Pauvert, O., Salvail, D., Rousseau, É., Lugnier, C., Marthan, R., & Savineau, J. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00919-x · Cited by 51
Chronic hypoxia attenuates cGMP-dependent pulmonary vasodilation
Jernigan, N. L., & Resta, T. C. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00273.2001 · Cited by 46
Mancini, M., Raina, R., Agarwal, A. K., NERVA, F., & Colpi, G. M. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901123 · Cited by 9
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,103
Metadata
- Authors
- Wharton, J., Strange, J. W., Møller, G. M. O., Growcott, E. J., Ren, X., Franklyn, A. P., Phillips, S. C., & Wilkins, M. R.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-01
- Volume
- 172
- Issue
- 1
- Pages
- 105-113
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2148797779
- Cited by
- 371
- References
- 41
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.